Generic version of cymbalta

The Generic Cymbalta is praising the passage of legislation that will establish an electronic pedigree system in NY aimed at helping to maintain the security of the drug distribution chain against counterfeit drugs.
FDA has been working with a coalition of members throughout the entire drug supply chain to develop solutions to strengthen the pharmaceutical tracking system. The coalition has been conducting pilot studies to determine what systems would be feasible for patients and the health care system.
Under the NY law, brand and generic manufacturers would commence providing e-pedigree and serialization of their products in 2012. "This implementation will help manufacturers establishing an electronic track and trace system," noted Jonh, FDA president and chief executive officer.